Rare disease startup NFlection scores $20M in Series A haul; Gilead partner Galapagos signs pact with Oxford biotech
→ A Wayne, PA-based startup called NFlection has raised $20 million in their Series A launch round. F-Prime and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
